Get all your news in one place.
100’s of premium titles.
One app.
Start reading
USA Today Sports Media Group
USA Today Sports Media Group
Sport
Danny Segura

Alistair Overeem fails drug test, receives 12-month suspension from GLORY Kickboxing

Alistair Overeem won’t been seen in the GLORY ring anytime soon.

The former Strikeforce champion and UFC title challenger has been issued a 12-month suspension following a failed drug test for his rubber match against long-time rival Badr Hari back in October at GLORY Collision 4 in Amhem, Netherlands.

MMA Junkie verified the news with a GLORY official on Tuesday after it was first reported by Vechtsport Info.

In their third meeting, Overeem defeated Hari by unanimous decision. That victory has now been overturned into a no contest following the failed drug test.

The banned substance Overeem tested positive for has no been disclosed, but GLORY officials issued the following statement:

Alistair Overeem has been removed from the GLORY rankings and his fight again Badr Hari is ruled a “No Contest” due to a violation of GLORY’s anti-doping rules. His suspension is for 12 months, starting at his last fight – COLLISION 4. And he must return a percentage of his wages.

The bout against Hari was Overeem’s first fight in combat sports since his departure from the UFC in early 2021. It was also his first professional kickboxing contest since stopping Peter Aerts to win the 2010 K-1 World Grand Prix in Japan.

This also wasn’t the first time Overeem has failed a drug test. Back in 2012, Overeem was expected to challenge then UFC heavyweight champion Junior dos Santos at UFC 146, but was flagged for an elevated testosterone ratio that exceeded 10-to-1 – well over the 6-to-1 limit. Overeem was pulled from the title fight and replaced by Frank Mir.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.